We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Comparative analysis evaluates toxicity and costs of CAR T-cell and lenalidomide maintenance after transplant, suggesting different implications for treatment choice.
No takes yet. Share an insight, caveat, or question.
Sadek et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: